Truist Financial analyst Jailendra Singh maintained a Hold rating on Doximity (DOCS – Research Report) on January 4 and set a price target of $28.00. The company’s shares closed last Friday at $28.10.
Singh covers the Healthcare sector, focusing on stocks such as R1 RCM, Evolent Health, and Agilon Health. According to TipRanks, Singh has an average return of -15.2% and a 33.54% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Doximity with a $26.75 average price target.
See the top stocks recommended by analysts >>
Based on Doximity’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $113.61 million and a net profit of $30.6 million. In comparison, last year the company earned a revenue of $102.19 million and had a net profit of $26.3 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Doximity (DOCS) Company Description:
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Read More on DOCS:
